O'Byrne Jason 4
4 · Vir Biotechnology, Inc. · Filed Nov 18, 2025
Insider Transaction Report
Form 4
O'Byrne Jason
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-17$5.56/sh−6,799$37,782→ 110,701 total
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.